Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
europe
fda
medical
research
study
atlantic food labs
berlin
bigdata
biotech
boehringer ingelheim
cbt
clinical trials
diabetes
diabetes2021
eli lilly
empagliflozin
europe blog main
europe top stories
fitness
foods
fundings & exits
health
healthcare
huel
indiana blog main
indiana top stories
life sciences
livongo
london
national blog main
national health service
new york blog main
new york top stories
obesity
prediabetes
recalls
recent funding
seedcamp
slgt2 inhibitor
What
diabetes
6
×
type
6
×
drug
medication
fda
patients
popular
program
risk
study
treat
used
year
aimed
alzheimer’s
approval
based
bid
blood
boehringer
cancer
catch
caused
combines
condition
cornell
decreased
dementia
developing
digital
disease
eli
evidence
expand
fallen
finds
food
free
habitual
healthtech
Language
unset
6
×
Current search:
type
×
diabetes
×
unset
×
@techcrunch.com
2 years ago
Habitual is using digital support plus food replacement to help reverse type 2 diabetes
@annagloyn
2 years ago
728384 medication orders for 159391 patients with type 2 diabetes #Diabetes2021 #bigdata https://t.co/QF80wUcaLb
@slashgear.com
3 years ago
Popular diabetes drug recalled months after FDA issued cancer risk warning
@slashgear.com
3 years ago
Another study finds metformin lowers dementia risk, but there’s a catch
@slashgear.com
3 years ago
Reversing type-2 diabetes study reports overwhelming success
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes